1.25 mg semaglutide Millions of Medicare beneficiaries to get affordable weight-loss drugs Ozempic® (semaglutide) Injection 0.25mg, 0.5

If you experience these symptoms, stop the medication and seek emergency medical care immediately

Novo Nordisk already has an oral version of semaglutide, the active ingredient in Ozempic and Wegovy, on the market in Rybelsus, which was first approved in 2019, but that is indicated for treating Type 2 diabetes, not obesity

This creates a powerful loop for energy management, especially during long-duration cardio or intense circuit training

Dont let location or a busy schedule hold you back from achieving your health and wellness goals

highest doses produced up to 14.7% weight loss Oral (VENTURE-Oral): Multiple dose cohorts including 90 mg studied over 13 weeks